Dow Investing Cash Flow increased by 33.0% to -$448.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.7%, from -$401.00M to -$448.00M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -7.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$755.00M | -$767.00M | -$1.38B | -$367.00M | -$396.00M | -$576.00M | -$1.63B | -$150.00M | -$684.00M | -$1.01B | -$1.08B | -$271.00M | -$494.00M | -$691.00M | -$912.00M | -$401.00M | -$561.00M | -$495.00M | -$669.00M | -$448.00M |
| QoQ Change | — | -1.6% | -79.8% | +73.4% | -7.9% | -45.5% | -183.2% | +90.8% | -356.0% | -48.0% | -6.9% | +75.0% | -82.3% | -39.9% | -32.0% | +56.0% | -39.9% | +11.8% | -35.2% | +33.0% |
| YoY Change | — | — | — | — | +47.5% | +24.9% | -18.3% | +59.1% | -72.7% | -75.7% | +33.7% | -80.7% | +27.8% | +31.7% | +15.7% | -48.0% | -13.6% | +28.4% | +26.6% | -11.7% |